» Articles » PMID: 32971831

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2020 Sep 25
PMID 32971831
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The interplay between glycolysis and mitochondrial oxidative phosphorylation (OXPHOS) is central to maintain energy homeostasis. It remains to be determined whether there is a mechanism governing metabolic fluxes based on substrate availability in microenvironments. Here we show that menin is a key transcription factor regulating the expression of OXPHOS and glycolytic genes in cancer cells and primary tumors with poor prognosis. A group of menin-associated proteins (MAPs), including KMT2A, MED12, WAPL, and GATA3, is found to restrain menin's full function in this transcription regulation. shRNA knockdowns of menin and MAPs result in reduced ATP production with proportional alterations of cellular energy generated through glycolysis and OXPHOS. When shRNA knockdown cells are exposed to metabolic stress, the dual functionality can clearly be distinguished among these metabolic regulators. A MAP can negatively counteract the regulatory mode of menin for OXPHOS while the same protein positively influences glycolysis. A close-proximity interaction between menin and MAPs allows transcriptional regulation for metabolic adjustment. This coordinate regulation by menin and MAPs is necessary for cells to rapidly adapt to fluctuating microenvironments and to maintain essential metabolic functions.

Citing Articles

Menin inhibitor MI-503 exhibits potent anti-cancer activity in osteosarcoma.

Tian S, Hao Z, Xu D, Wang X, Shi C, Zhang Y Sci Rep. 2025; 15(1):7059.

PMID: 40016386 PMC: 11868418. DOI: 10.1038/s41598-025-91351-y.


Elucidating the roles of SOD3 correlated genes and reactive oxygen species in rare human diseases using a bioinformatic-ontology approach.

Stanworth M, Zhang S PLoS One. 2024; 19(10):e0313139.

PMID: 39480826 PMC: 11527182. DOI: 10.1371/journal.pone.0313139.


Metabolism of pancreatic neuroendocrine tumors: what can omics tell us?.

Jannin A, Dessein A, Do Cao C, Vantyghem M, Chevalier B, Van Seuningen I Front Endocrinol (Lausanne). 2023; 14:1248575.

PMID: 37908747 PMC: 10613989. DOI: 10.3389/fendo.2023.1248575.


Menin-MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and Cancers.

Shi Q, Xu M, Kang Z, Zhang M, Luo Y Molecules. 2023; 28(7).

PMID: 37049787 PMC: 10095982. DOI: 10.3390/molecules28073026.


MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumors.

Ye Z, Chen H, Ji S, Hu Y, Lou X, Zhang W Acta Biochim Biophys Sin (Shanghai). 2023; 54(11):1599-1609.

PMID: 36604142 PMC: 9828289. DOI: 10.3724/abbs.2022162.


References
1.
Quiros P, Mottis A, Auwerx J . Mitonuclear communication in homeostasis and stress. Nat Rev Mol Cell Biol. 2016; 17(4):213-26. DOI: 10.1038/nrm.2016.23. View

2.
Thakker R, Newey P, Walls G, Bilezikian J, Dralle H, Ebeling P . Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012; 97(9):2990-3011. DOI: 10.1210/jc.2012-1230. View

3.
Huang J, Gurung B, Wan B, Matkar S, Veniaminova N, Wan K . The same pocket in menin binds both MLL and JUND but has opposite effects on transcription. Nature. 2012; 482(7386):542-6. PMC: 3983792. DOI: 10.1038/nature10806. View

4.
Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero D, Kitabayashi I . Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol. 2004; 24(13):5639-49. PMC: 480881. DOI: 10.1128/MCB.24.13.5639-5649.2004. View

5.
Chen C, Mahalingam D, Osmulski P, Jadhav R, Wang C, Leach R . Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. Prostate. 2013; 73(8):813-26. PMC: 4882087. DOI: 10.1002/pros.22625. View